-
EP3351246
European procedure
Extract from the Register of European Patents
EP About this file: EP3351246
| EP3351246 - RAPAMYCIN DERIVATIVE FOR THE TREATMENT OF A SOLID TUMOR ASSOCIATED WITH DEREGULATED ANGIOGENESIS [Right-click to bookmark this link] | Status | Patent revoked Status updated on 23.10.2023 Database last updated on 20.11.2024 | |
| Former | The patent has been granted Status updated on 19.04.2019 | ||
| Former | Grant of patent is intended Status updated on 09.04.2019 | ||
| Former | Examination is in progress Status updated on 18.01.2019 | ||
| Former | Request for examination was made Status updated on 22.06.2018 | Most recent event Tooltip | 27.10.2023 | Revocation of patent | published on 29.11.2023 [2023/48] | 27.10.2023 | Opposition withdrawn | published on 29.11.2023 [2023/48] | Applicant(s) | For all designated states Novartis Pharma AG Lichtstrasse 35 4056 Basel / CH | [2020/36] |
| Former [2019/26] | For all designated states Novartis Pharma AG Lichtstrasse 35 4056 Basel / CH | ||
| For all designated states Novartis International Pharmaceutical AG Lichtstrasse 35 4056 Basel / CH | |||
| Former [2019/21] | For all designated states Novartis AG Lichtstrasse 35 4056 Basel / CH | ||
| Former [2018/30] | For all designated states Novartis AG Lichtstrasse 35 4056 Basel / CH | Inventor(s) | 01 /
Lane, Heidi Kaltbrunnenweg 8 4106 Therwill / CH | 02 /
O`Reilly, Terence Drahtzugstrasse 51 4057 Basel / CH | 03 /
Wood, Jeanette Marjorie In den Kleematten 18 4105 Biel-Benken / CH | [2018/30] | Representative(s) | Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [2019/21] |
| Former [2018/30] | Kristl, Jernej Novartis Pharma AG IP Patent Department Forum 1 Novartis Campus 4056 Basel / CH | Application number, filing date | 18155644.0 | 18.02.2002 | [2018/30] | Priority number, date | GB20010004072 | 19.02.2001 Original published format: GB 0104072 | GB20010024957 | 17.10.2001 Original published format: GB 0124957 | [2018/30] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3351246 | Date: | 25.07.2018 | Language: | EN | [2018/30] | Type: | B1 Patent specification | No.: | EP3351246 | Date: | 22.05.2019 | Language: | EN | [2019/21] | Type: | B8 Corrected title page of specification | No.: | EP3351246 | Date: | 18.09.2019 | [2019/38] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 07.06.2018 | Classification | IPC: | A61K31/436, A61P35/00, A61P35/04 | [2018/30] | CPC: |
A61K31/436 (EP,CN,CZ,IL,KR,NO,RU,US);
A61K31/337 (EP,IL,US);
A61K31/366 (EP,IL,US);
A61K31/4196 (EP,IL,NO,US);
A61K31/439 (US);
A61K31/451 (EP,US);
A61K31/4545 (EP,US);
A61K31/4745 (US);
A61K31/475 (EP,US);
A61K31/502 (EP,US);
A61K31/555 (EP,US);
A61K31/5685 (EP,US);
A61K31/58 (EP,US);
A61K31/704 (EP,US);
A61K31/7068 (EP,US);
A61K33/243 (EP,CN,NO,RU,US);
A61K39/3955 (US);
A61K39/39558 (US);
A61K45/06 (EP,IL,US);
A61P1/02 (EP);
A61P1/04 (EP);
A61P1/16 (EP);
A61P1/18 (EP);
A61P11/00 (EP);
A61P11/02 (EP);
A61P11/04 (EP);
A61P13/00 (EP);
A61P13/02 (EP);
A61P13/10 (EP);
A61P13/12 (EP);
A61P15/00 (EP);
A61P15/14 (EP);
A61P17/00 (EP);
A61P19/00 (EP);
A61P21/00 (EP);
A61P25/00 (EP);
A61P25/02 (EP);
A61P27/02 (EP);
A61P27/16 (EP);
A61P3/00 (EP);
A61P35/00 (EP,CZ,NO,RU);
A61P35/02 (EP);
A61P35/04 (EP,NO);
A61P43/00 (EP);
A61P5/00 (EP);
A61P5/28 (EP);
A61P5/32 (EP);
A61P9/00 (EP);
| C-Set: |
A61K31/337, A61K2300/00 (US,EP);
A61K31/366, A61K2300/00 (US,EP);
A61K31/4196, A61K2300/00 (EP,US);
A61K31/436, A61K2300/00 (US,EP);
A61K31/436, A61K31/4196 (US);
A61K31/451, A61K2300/00 (US,EP);
A61K31/4545, A61K2300/00 (EP,US);
A61K31/475, A61K2300/00 (US,EP);
A61K31/502, A61K2300/00 (US,EP);
A61K31/555, A61K2300/00 (US,EP);
A61K31/5685, A61K2300/00 (EP,US);
A61K31/58, A61K2300/00 (US,EP);
A61K31/704, A61K2300/00 (US,EP);
A61K31/7068, A61K2300/00 (US,EP); | Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2018/30] | Extension states | LT | 07.02.2018 | LV | 07.02.2018 | RO | 07.02.2018 | SI | 07.02.2018 | Title | German: | RAPAMYCIN-DERIVAT ZUR BEHANDLUNG EINES SOLIDEN TUMORS, DER MIT DEREGULIERTER ANGIOGENESE ASSOZIIERT IST | [2018/30] | English: | RAPAMYCIN DERIVATIVE FOR THE TREATMENT OF A SOLID TUMOR ASSOCIATED WITH DEREGULATED ANGIOGENESIS | [2018/30] | French: | DÉRIVÉ DE RAPAMYCINE POUR LE TRAITEMENT D'UNE TUMEUR SOLIDE ASSOCIÉE À UNE ANGIOGENÈSE DÉRÉGULÉE | [2018/30] | Examination procedure | 07.02.2018 | Examination requested [2018/30] | 07.02.2018 | Date on which the examining division has become responsible | 25.07.2018 | Amendment by applicant (claims and/or description) | 06.12.2018 | Observations by third parties | 12.12.2018 | Observations by third parties | 18.01.2019 | Despatch of a communication from the examining division (Time limit: M04) | 19.03.2019 | Reply to a communication from the examining division | 10.04.2019 | Communication of intention to grant the patent | 12.04.2019 | Fee for grant paid | 12.04.2019 | Fee for publishing/printing paid | 12.04.2019 | Receipt of the translation of the claim(s) | 25.04.2019 | Observations by third parties | Parent application(s) Tooltip | EP02719864.7 / EP1363627 | EP14164259.5 / EP2783686 | EP16186041.6 / EP3143995 | Opposition(s) | Opponent(s) | 01
23.05.2019
28.05.2019
ADMISSIBLE STADA Arzneimittel AG Stadastrasse 2-18 61118 Bad Vilbel / DE Opponent's representative Hamm&Wittkopp Patentanwälte PartmbB, et al, et al Jungfernstieg 38 20354 Hamburg / DE | 02
01.07.2019
04.07.2019
ADMISSIBLE BIOGARAN 15 Boulevard Charles de Gaulle 92707 COLOMBES / FR Opponent's representative Casalonga Casalonga & Partners Bayerstraße 71/73 80335 München / DE | 03
03.07.2019
08.07.2019
ADMISSIBLE Ethypharm 194 Bureaux de la Colline 92213 Saint-Cloud / FR Opponent's representative LLR, et al, et al 2, rue Jean Lantier 75001 Paris / FR | 04
31.07.2019
25.09.2023
WITHDRAWN Accord Healthcare Ltd Sage House 319 Pinner Road North Harrow Middlesex HA1 4HF / GB Opponent's representative Plougmann Vingtoft a/s Strandvejen 70 2900 Hellerup / DK | 05
16.09.2019
19.09.2019
ADMISSIBLE Zentiva Pharma GmbH Brüningstrasse 50 65926 Frankfurt am Main / DE Opponent's representative Bird & Bird LLP Maximiliansplatz 22 80333 München / DE | 06
29.01.2020
31.01.2020
ADMISSIBLE Dr. Reddy's Laboratories Ltd./ Betapharm Arzneimittel GmbH 8-2-337 Road No. 3 /Kobelweg 95 Banjara Hills Hyderabad 500034 Telangana IN / 86156 Augsburg DE / IN Opponent's representative Maiwald GmbH, et al, et al Elisenhof Elisenstraße 3 80335 München / DE | 07
21.02.2020
26.02.2020
ADMISSIBLE Generics [UK] Limited Station Close Potters Bar Hertfordshire EN6 1TL / GB Opponent's representative Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB | 08
22.02.2020
26.02.2020
ADMISSIBLE Teva Pharmaceutical Industries Ltd. 124 Dvora HaNevi'a St. Tel Aviv 6944020 / IL Opponent's representative August Debouzy 7, rue de Téhéran 75008 Paris / FR | 09
24.02.2020
26.02.2020
ADMISSIBLE ARROW GENERIQUES 26 avenue Tony Garnier 69007 Lyon / FR Opponent's representative Tripoz, Inès Cabinet Tripoz Le Pôle Sud 22 rue Seguin 69002 Lyon / FR | [N/P] |
| Former [2023/48] | |||
| Opponent(s) | 01
23.05.2019
28.05.2019
ADMISSIBLE STADA Arzneimittel AG Stadastrasse 2-18 61118 Bad Vilbel / DE Opponent's representative Hamm&Wittkopp Patentanwälte PartmbB, et al, et al Jungfernstieg 38 20354 Hamburg / DE | ||
| 02
01.07.2019
04.07.2019
ADMISSIBLE BIOGARAN 15 Boulevard Charles de Gaulle 92707 COLOMBES / FR Opponent's representative Casalonga Casalonga & Partners Bayerstraße 71/73 80335 München / DE | |||
| 03
03.07.2019
08.07.2019
ADMISSIBLE Ethypharm 194 Bureaux de la Colline 92213 Saint-Cloud / FR Opponent's representative LLR, et al, et al 11, boulevard de Sébastopol 75001 Paris / FR | |||
| 04
31.07.2019
25.09.2023
WITHDRAWN Accord Healthcare Ltd Sage House 319 Pinner Road North Harrow Middlesex HA1 4HF / GB Opponent's representative Plougmann Vingtoft a/s Strandvejen 70 2900 Hellerup / DK | |||
| 05
16.09.2019
19.09.2019
ADMISSIBLE Zentiva Pharma GmbH Brüningstrasse 50 65926 Frankfurt am Main / DE Opponent's representative Bird & Bird LLP Maximiliansplatz 22 80333 München / DE | |||
| 06
29.01.2020
31.01.2020
ADMISSIBLE Dr. Reddy's Laboratories Ltd./ Betapharm Arzneimittel GmbH 8-2-337 Road No. 3 /Kobelweg 95 Banjara Hills Hyderabad 500034 Telangana IN / 86156 Augsburg DE / IN Opponent's representative Maiwald GmbH, et al, et al Elisenhof Elisenstraße 3 80335 München / DE | |||
| 07
21.02.2020
26.02.2020
ADMISSIBLE Generics [UK] Limited Station Close Potters Bar Hertfordshire EN6 1TL / GB Opponent's representative Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB | |||
| 08
22.02.2020
26.02.2020
ADMISSIBLE Teva Pharmaceutical Industries Ltd. 124 Dvora HaNevi'a St. Tel Aviv 6944020 / IL Opponent's representative August Debouzy 7, rue de Téhéran 75008 Paris / FR | |||
| 09
24.02.2020
26.02.2020
ADMISSIBLE ARROW GENERIQUES 26 avenue Tony Garnier 69007 Lyon / FR Opponent's representative Tripoz, Inès Cabinet Tripoz Le Pôle Sud 22 rue Seguin 69002 Lyon / FR | |||
| Former [2023/08] | |||
| Opponent(s) | 01
23.05.2019
28.05.2019
ADMISSIBLE STADA Arzneimittel AG Stadastrasse 2-18 61118 Bad Vilbel / DE Opponent's representative Hamm&Wittkopp Patentanwälte PartmbB, et al, et al Jungfernstieg 38 20354 Hamburg / DE | ||
| 02
01.07.2019
04.07.2019
ADMISSIBLE BIOGARAN 15 Boulevard Charles de Gaulle 92707 COLOMBES / FR Opponent's representative Casalonga Casalonga & Partners Bayerstraße 71/73 80335 München / DE | |||
| 03
03.07.2019
08.07.2019
ADMISSIBLE Ethypharm 194 Bureaux de la Colline 92213 Saint-Cloud / FR Opponent's representative LLR, et al, et al 11, boulevard de Sébastopol 75001 Paris / FR | |||
| 04
31.07.2019
20.02.2020
ADMISSIBLE Accord Healthcare Ltd Sage House 319 Pinner Road North Harrow Middlesex HA1 4HF / GB Opponent's representative Plougmann Vingtoft a/s Strandvejen 70 2900 Hellerup / DK | |||
| 05
16.09.2019
19.09.2019
ADMISSIBLE Zentiva Pharma GmbH Brüningstrasse 50 65926 Frankfurt am Main / DE Opponent's representative Bird & Bird LLP Maximiliansplatz 22 80333 München / DE | |||
| 06
29.01.2020
31.01.2020
ADMISSIBLE Dr. Reddy's Laboratories Ltd./ Betapharm Arzneimittel GmbH 8-2-337 Road No. 3 /Kobelweg 95 Banjara Hills Hyderabad 500034 Telangana IN / 86156 Augsburg DE / IN Opponent's representative Maiwald GmbH, et al, et al Elisenhof Elisenstraße 3 80335 München / DE | |||
| 07
21.02.2020
26.02.2020
ADMISSIBLE Generics [UK] Limited Station Close Potters Bar Hertfordshire EN6 1TL / GB Opponent's representative Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB | |||
| 08
22.02.2020
26.02.2020
ADMISSIBLE Teva Pharmaceutical Industries Ltd. 124 Dvora HaNevi'a St. Tel Aviv 6944020 / IL Opponent's representative August Debouzy 7, rue de Téhéran 75008 Paris / FR | |||
| 09
24.02.2020
26.02.2020
ADMISSIBLE ARROW GENERIQUES 26 avenue Tony Garnier 69007 Lyon / FR Opponent's representative Tripoz, Inès Cabinet Tripoz Le Pôle Sud 22 rue Seguin 69002 Lyon / FR | |||
| Former [2023/04] | |||
| Opponent(s) | 01
23.05.2019
28.05.2019
ADMISSIBLE STADA Arzneimittel AG Stadastrasse 2-18 61118 Bad Vilbel / DE Opponent's representative Hamm&Wittkopp Patentanwälte PartmbB, et al, et al Jungfernstieg 38 20354 Hamburg / DE | ||
| 02
01.07.2019
04.07.2019
ADMISSIBLE BIOGARAN 15 Boulevard Charles de Gaulle 92707 COLOMBES / FR Opponent's representative Casalonga Casalonga & Partners Bayerstraße 71/73 80335 München / DE | |||
| 03
03.07.2019
08.07.2019
ADMISSIBLE Ethypharm 194 Bureaux de la Colline 92213 Saint-Cloud / FR Opponent's representative LLR, et al, et al 11, boulevard de Sébastopol 75001 Paris / FR | |||
| 04
31.07.2019
20.02.2020
ADMISSIBLE Accord Healthcare Ltd Sage House 319 Pinner Road North Harrow Middlesex HA1 4HF / GB Opponent's representative Plougmann Vingtoft a/s Strandvejen 70 2900 Hellerup / DK | |||
| 05
16.09.2019
19.09.2019
ADMISSIBLE Zentiva Pharma GmbH Brüningstrasse 50 65926 Frankfurt am Main / DE Opponent's representative Bird & Bird LLP Maximiliansplatz 22 80333 München / DE | |||
| 06
29.01.2020
31.01.2020
ADMISSIBLE Dr. Reddy's Laboratories Ltd./ Betapharm Arzneimittel GmbH 8-2-337 Road No. 3 /Kobelweg 95 Banjara Hills Hyderabad 500034 Telangana IN / 86156 Augsburg DE / IN Opponent's representative Maiwald GmbH, et al, et al Elisenhof Elisenstraße 3 80335 München / DE | |||
| 07
21.02.2020
26.02.2020
ADMISSIBLE Generics [UK] Limited Station Close Potters Bar Hertfordshire EN6 1TL / GB Opponent's representative Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB | |||
| 08
22.02.2020
26.02.2020
ADMISSIBLE Teva Pharmaceutical Industries Ltd. 124 Dvora HaNevi'a St. Tel Aviv 6944020 / IL Opponent's representative Schiener, Jens Wächtershäuser & Hartz Patentanwaltspartnerschaft mbB Weinstraße 8 80333 München / DE | |||
| 09
24.02.2020
26.02.2020
ADMISSIBLE ARROW GENERIQUES 26 avenue Tony Garnier 69007 Lyon / FR Opponent's representative Tripoz, Inès Cabinet Tripoz Le Pôle Sud 22 rue Seguin 69002 Lyon / FR | |||
| Former [2021/48] | |||
| Opponent(s) | 01
23.05.2019
28.05.2019
ADMISSIBLE STADA Arzneimittel AG Stadastrasse 2-18 61118 Bad Vilbel / DE Opponent's representative Hamm&Wittkopp Patentanwälte PartmbB, et al, et al Jungfernstieg 38 20354 Hamburg / DE | ||
| 02
01.07.2019
04.07.2019
ADMISSIBLE BIOGARAN 15 Boulevard Charles de Gaulle 92707 COLOMBES / FR Opponent's representative Casalonga Casalonga & Partners Bayerstraße 71/73 80335 München / DE | |||
| 03
03.07.2019
08.07.2019
ADMISSIBLE Ethypharm 194 Bureaux de la Colline 92213 Saint-Cloud / FR Opponent's representative LLR, et al, et al 11 boulevard de Sébastopol 75001 Paris / FR | |||
| 04
31.07.2019
20.02.2020
ADMISSIBLE Accord Healthcare Ltd Sage House 319 Pinner Road North Harrow Middlesex HA1 4HF / GB Opponent's representative Plougmann Vingtoft a/s Strandvejen 70 2900 Hellerup / DK | |||
| 05
16.09.2019
19.09.2019
ADMISSIBLE Zentiva Pharma GmbH Brüningstrasse 50 65926 Frankfurt am Main / DE Opponent's representative Bird & Bird LLP Maximiliansplatz 22 80333 München / DE | |||
| 06
29.01.2020
31.01.2020
ADMISSIBLE Dr. Reddy's Laboratories Ltd./ Betapharm Arzneimittel GmbH 8-2-337 Road No. 3 /Kobelweg 95 Banjara Hills Hyderabad 500034 Telangana IN / 86156 Augsburg DE / IN Opponent's representative Wünsche, Annelie, et al, et al Maiwald Patentanwalts- und Rechtsanwaltsgesellschaft mbH Elisenhof Elisenstraße 3 80335 München / DE | |||
| 07
21.02.2020
26.02.2020
ADMISSIBLE Generics [UK] Limited Station Close Potters Bar Hertfordshire EN6 1TL / GB Opponent's representative Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB | |||
| 08
22.02.2020
26.02.2020
ADMISSIBLE Teva Pharmaceutical Industries Ltd. 124 Dvora HaNevi'a St. Tel Aviv 6944020 / IL Opponent's representative Schiener, Jens Wächtershäuser & Hartz Patentanwaltspartnerschaft mbB Weinstraße 8 80333 München / DE | |||
| 09
24.02.2020
26.02.2020
ADMISSIBLE ARROW GENERIQUES 26 avenue Tony Garnier 69007 Lyon / FR Opponent's representative Tripoz, Inès Cabinet Tripoz Le Pôle Sud 22 rue Seguin 69002 Lyon / FR | |||
| Former [2021/20] | |||
| Opponent(s) | 01
23.05.2019
28.05.2019
ADMISSIBLE STADA Arzneimittel AG Stadastrasse 2-18 61118 Bad Vilbel / DE Opponent's representative Hamm&Wittkopp Patentanwälte PartmbB, et al, et al Jungfernstieg 38 20354 Hamburg / DE | ||
| 02
01.07.2019
04.07.2019
ADMISSIBLE BIOGARAN 15 Boulevard Charles de Gaulle 92707 COLOMBES / FR Opponent's representative Casalonga Casalonga & Partners Bayerstraße 71/73 80335 München / DE | |||
| 03
03.07.2019
08.07.2019
ADMISSIBLE Ethypharm 194 Bureaux de la Colline 92213 Saint-Cloud / FR Opponent's representative LLR, et al, et al 11 boulevard de Sébastopol 75001 Paris / FR | |||
| 04
31.07.2019
20.02.2020
ADMISSIBLE Accord Healthcare Ltd Sage House 319 Pinner Road North Harrow Middlesex HA1 4HF / GB Opponent's representative Plougmann Vingtoft a/s Strandvejen 70 2900 Hellerup / DK | |||
| 05
16.09.2019
19.09.2019
ADMISSIBLE Zentiva Pharma GmbH Brüningstrasse 50 65926 Frankfurt am Main / DE Opponent's representative Bird & Bird LLP Maximiliansplatz 22 80333 München / DE | |||
| 06
29.01.2020
31.01.2020
ADMISSIBLE Dr. Reddy's Laboratories Ltd./ Betapharm Arzneimittel GmbH 8-2-337 Road No. 3 /Kobelweg 95 Banjara Hills Hyderabad 500034 Telangana IN / 86156 Augsburg DE / IN Opponent's representative Wünsche, Annelie, et al, et al Maiwald Patentanwalts- und Rechtsanwaltsgesellschaft mbH Elisenhof Elisenstraße 3 80335 München / DE | |||
| 07
21.02.2020
26.02.2020
ADMISSIBLE Generics [UK] Limited Station Close Potters Bar Hertfordshire EN6 1TL / GB Opponent's representative Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB | |||
| 08
22.02.2020
26.02.2020
ADMISSIBLE Teva Pharmaceutical Industries Ltd 5 Basel Street 49131 Petach-Tikva / IL Opponent's representative Schiener, Jens Wächtershäuser & Hartz Patentanwaltspartnerschaft mbB Weinstraße 8 80333 München / DE | |||
| 09
24.02.2020
26.02.2020
ADMISSIBLE ARROW GENERIQUES 26 avenue Tony Garnier 69007 Lyon / FR Opponent's representative Tripoz, Inès Cabinet Tripoz Le Pôle Sud 22 rue Seguin 69002 Lyon / FR | |||
| Former [2020/14] | |||
| Opponent(s) | 01
23.05.2019
28.05.2019
ADMISSIBLE STADA Arzneimittel AG Stadastrasse 2-18 61118 Bad Vilbel / DE Opponent's representative Hamm&Wittkopp Patentanwälte PartmbB, et al, et al Jungfernstieg 38 20354 Hamburg / DE | ||
| 02
01.07.2019
04.07.2019
ADMISSIBLE BIOGARAN 15 Boulevard Charles de Gaulle 92707 COLOMBES / FR Opponent's representative Casalonga Casalonga & Partners Bayerstraße 71/73 80335 München / DE | |||
| 03
03.07.2019
08.07.2019
ADMISSIBLE Ethypharm 194 Bureaux de la Colline 92213 Saint-Cloud / FR Opponent's representative LLR, et al, et al 11 boulevard de Sébastopol 75001 Paris / FR | |||
| 04
31.07.2019
20.02.2020
ADMISSIBLE Accord Healthcare Ltd Sage House 319 Pinner Road North Harrow Middlesex HA1 4HF / GB Opponent's representative Plougmann Vingtoft a/s Strandvejen 70 2900 Hellerup / DK | |||
| 05
16.09.2019
19.09.2019
ADMISSIBLE Zentiva Pharma GmbH Brüningstrasse 50 65926 Frankfurt am Main / DE Opponent's representative Bird & Bird LLP Maximiliansplatz 22 80333 München / DE | |||
| 06
29.01.2020
31.01.2020
ADMISSIBLE Dr. Reddy's Laboratories Ltd./ Betapharm Arzneimittel GmbH 8-2-337 Road No. 3 /Kobelweg 95 Banjara Hills Hyderabad 500034 Telangana IN / 86156 Augsburg DE / IN Opponent's representative Wünsche, Annelie, et al, et al Maiwald Patentanwalts- und Rechtsanwaltsgesellschaft mbH Elisenhof Elisenstraße 3 80335 München / DE | |||
| 07
21.02.2020
26.02.2020
ADMISSIBLE Generics [UK] Limited Station Close Potters Bar Hertfordshire EN6 1TL / GB Opponent's representative Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB | |||
| 08
22.02.2020
26.02.2020
ADMISSIBLE Teva Pharmaceutical Industries Ltd 5 Basel Street 49131 Petach-Tikva / IL Opponent's representative Schiener, Jens Wächtershäuser & Hartz Patentanwaltspartnerschaft mbB Weinstraße 8 80333 München / DE | |||
| 09
24.02.2020
26.02.2020
ADMISSIBLE ARROW GENERIQUES 26 avenue Tony Garnier 69007 Lyon / FR Opponent's representative Tripoz, Inès Cabinet Tripoz Le Pôle Sud 22 rue Seguin 69002 Lyon / FR | |||
| Former [2020/10] | |||
| Opponent(s) | 01
23.05.2019
28.05.2019
ADMISSIBLE STADA Arzneimittel AG Stadastrasse 2-18 61118 Bad Vilbel / DE Opponent's representative Hamm&Wittkopp Patentanwälte PartmbB, et al, et al Jungfernstieg 38 20354 Hamburg / DE | ||
| 02
01.07.2019
04.07.2019
ADMISSIBLE BIOGARAN 15 Boulevard Charles de Gaulle 92707 COLOMBES / FR Opponent's representative Casalonga Casalonga & Partners Bayerstraße 71/73 80335 München / DE | |||
| 03
03.07.2019
08.07.2019
ADMISSIBLE Ethypharm 194 Bureaux de la Colline 92213 Saint-Cloud / FR Opponent's representative LLR, et al, et al 11, boulevard de Sébastopol 75001 Paris / FR | |||
| 04
31.07.2019
ADMISSIBLE Accord Healthcare Ltd Sage House 319 Pinner Road North Harrow Middlesex HA1 4HF / GB Opponent's representative Plougmann Vingtoft a/s Strandvejen 70 2900 Hellerup / DK | |||
| 05
16.09.2019
19.09.2019
ADMISSIBLE Zentiva Pharma GmbH Brüningstrasse 50 65926 Frankfurt am Main / DE Opponent's representative Bird & Bird LLP Maximiliansplatz 22 80333 München / DE | |||
| 06
29.01.2020
Dr. Reddy's Laboratories Limited 8-2-337, Road No. 3 Banjara Hills Telangana 500034 Hyderabad / IN Opponent's representative Wünsche, Annelie, et al, et al Maiwald Patentanwalts- und Rechtsanwaltsgesellschaft mbH Elisenhof Elisenstraße 3 80335 München / DE | |||
| Former [2019/43] | |||
| Opponent(s) | 01
23.05.2019
28.05.2019
ADMISSIBLE STADA Arzneimittel AG Stadastrasse 2-18 61118 Bad Vilbel / DE Opponent's representative Hamm&Wittkopp Patentanwälte PartmbB, et al, et al Jungfernstieg 38 20354 Hamburg / DE | ||
| 02
01.07.2019
04.07.2019
ADMISSIBLE BIOGARAN 15 Boulevard Charles de Gaulle 92707 COLOMBES / FR Opponent's representative Casalonga Casalonga & Partners Bayerstraße 71/73 80335 München / DE | |||
| 03
03.07.2019
08.07.2019
ADMISSIBLE Ethypharm 194 Bureaux de la Colline 92213 Saint-Cloud / FR Opponent's representative LLR, et al, et al 11, boulevard de Sébastopol 75001 Paris / FR | |||
| 04
31.07.2019
Accord Healthcare Ltd Sage House 319 Pinner Road North Harrow Middlesex HA1 4HF / GB Opponent's representative Plougmann Vingtoft a/s Strandvejen 70 2900 Hellerup / DK | |||
| 05
16.09.2019
19.09.2019
ADMISSIBLE Zentiva Pharma GmbH Brüningstrasse 50 65926 Frankfurt am Main / DE Opponent's representative Bird & Bird LLP Maximiliansplatz 22 80333 München / DE | |||
| Former [2019/37] | |||
| Opponent(s) | 01
23.05.2019
28.05.2019
ADMISSIBLE STADA Arzneimittel AG Stadastrasse 2-18 61118 Bad Vilbel / DE Opponent's representative Hamm&Wittkopp Patentanwälte PartmbB, et al, et al Jungfernstieg 38 20354 Hamburg / DE | ||
| 02
01.07.2019
04.07.2019
ADMISSIBLE BIOGARAN 15 Boulevard Charles de Gaulle 92707 COLOMBES / FR Opponent's representative Casalonga Casalonga & Partners Bayerstraße 71/73 80335 München / DE | |||
| 03
03.07.2019
08.07.2019
ADMISSIBLE Ethypharm 194 Bureaux de la Colline 92213 Saint-Cloud / FR Opponent's representative LLR, et al, et al 11, boulevard de Sébastopol 75001 Paris / FR | |||
| 04
31.07.2019
Accord Healthcare Ltd Sage House 319 Pinner Road North Harrow Middlesex HA1 4HF / GB Opponent's representative Plougmann Vingtoft a/s Strandvejen 70 2900 Hellerup / DK | |||
| Former [2019/32] | |||
| Opponent(s) | 01
23.05.2019
28.05.2019
ADMISSIBLE STADA Arzneimittel AG Stadastrasse 2-18 61118 Bad Vilbel / DE Opponent's representative Hamm&Wittkopp Patentanwälte PartmbB, et al, et al Jungfernstieg 38 20354 Hamburg / DE | ||
| 02
01.07.2019
04.07.2019
ADMISSIBLE BIOGARAN 15 Boulevard Charles de Gaulle 92707 COLOMBES / FR Opponent's representative Casalonga Casalonga & Partners Bayerstraße 71/73 80335 München / DE | |||
| 03
03.07.2019
ADMISSIBLE Ethypharm 194 Bureaux de la Colline 92213 Saint-Cloud / FR Opponent's representative LLR, et al, et al 11, boulevard de Sébastopol 75001 Paris / FR | |||
| Former [2019/27] | |||
| Opponent(s) | 01
23.05.2019
28.05.2019
ADMISSIBLE STADA Arzneimittel AG Stadastrasse 2-18 61118 Bad Vilbel / DE Opponent's representative Hamm&Wittkopp Patentanwälte PartmbB, et al, et al Jungfernstieg 38 20354 Hamburg / DE | deleted | Deletion: Legal effect of rejection of opposition [ N /P ] | 12.08.2019 | No. 04: Notification indicating deficiencies in the notice of opposition | 20.02.2020 | No. 04: Reply to notification indicating deficiencies in the notice of opposition | 11.03.2020 | Invitation to proprietor to file observations on the notice of opposition | 21.07.2020 | Reply of patent proprietor to notice(s) of opposition | 30.03.2022 | Date of despatch of rejection of opposition | 28.07.2023 | Legal effect of revocation of patent [2023/48] | 16.10.2023 | Despatch of communication that the patent will be revoked | Appeal following opposition | 22.05.2022 | Appeal received No. T0814/22 | 22.05.2022 | Payment of appeal fee | 09.08.2022 | Statement of grounds filed | 28.07.2023 | Result of appeal procedure: revocation of the patent | 16.10.2023 | Despatch of the decision of the Board of Appeal | 31.03.2022 | Appeal received No. T0814/22 | 31.03.2022 | Payment of appeal fee | 09.08.2022 | Statement of grounds filed | 28.07.2023 | Result of appeal procedure: revocation of the patent | 16.10.2023 | Despatch of the decision of the Board of Appeal | 10.11.2021 | Appeal received No. T0814/22 | 10.11.2021 | Payment of appeal fee | 08.08.2022 | Statement of grounds filed | 28.07.2023 | Result of appeal procedure: revocation of the patent | 16.10.2023 | Despatch of the decision of the Board of Appeal | 17.05.2022 | Appeal received No. T0814/22 | 17.05.2022 | Payment of appeal fee | 05.08.2022 | Statement of grounds filed | 28.07.2023 | Result of appeal procedure: revocation of the patent | 16.10.2023 | Despatch of the decision of the Board of Appeal | 08.06.2022 | Appeal received No. T0814/22 | 08.06.2022 | Payment of appeal fee | 04.08.2022 | Statement of grounds filed | 28.07.2023 | Result of appeal procedure: revocation of the patent | 16.10.2023 | Despatch of the decision of the Board of Appeal | 05.04.2022 | Appeal received No. T0814/22 | 05.04.2022 | Payment of appeal fee | 01.08.2022 | Statement of grounds filed | 28.07.2023 | Result of appeal procedure: revocation of the patent | 16.10.2023 | Despatch of the decision of the Board of Appeal | 19.11.2021 | Appeal received No. T0814/22 | 19.11.2021 | Payment of appeal fee | 01.08.2022 | Statement of grounds filed | 28.07.2023 | Result of appeal procedure: revocation of the patent | 16.10.2023 | Despatch of the decision of the Board of Appeal | 27.10.2021 | Appeal received No. T0814/22 | 27.10.2021 | Payment of appeal fee | 22.07.2022 | Statement of grounds filed | 28.07.2023 | Result of appeal procedure: revocation of the patent | 16.10.2023 | Despatch of the decision of the Board of Appeal | 08.11.2021 | Appeal received No. T0814/22 | 08.11.2021 | Payment of appeal fee | 08.07.2022 | Statement of grounds filed | 28.07.2023 | Result of appeal procedure: revocation of the patent | 16.10.2023 | Despatch of the decision of the Board of Appeal | 19.10.2021 | Date of oral proceedings | 30.03.2022 | Minutes of the oral proceedings despatched | 27.07.2023 | Date of oral proceedings | Fees paid | Renewal fee | 07.02.2018 | Renewal fee patent year 03 | 07.02.2018 | Renewal fee patent year 04 | 07.02.2018 | Renewal fee patent year 05 | 07.02.2018 | Renewal fee patent year 06 | 07.02.2018 | Renewal fee patent year 07 | 07.02.2018 | Renewal fee patent year 08 | 07.02.2018 | Renewal fee patent year 09 | 07.02.2018 | Renewal fee patent year 10 | 07.02.2018 | Renewal fee patent year 11 | 07.02.2018 | Renewal fee patent year 12 | 07.02.2018 | Renewal fee patent year 13 | 07.02.2018 | Renewal fee patent year 14 | 07.02.2018 | Renewal fee patent year 15 | 07.02.2018 | Renewal fee patent year 16 | 07.02.2018 | Renewal fee patent year 17 | 13.02.2019 | Renewal fee patent year 18 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | GB | 17.02.2022 | IE | 18.02.2022 | ES | 19.02.2022 | PT | 01.03.2022 | [2022/34] |
| Former [2022/25] | GB | 17.02.2022 | |
| IE | 18.02.2022 | ||
| PT | 01.03.2022 | ||
| Former [2022/22] | GB | 17.02.2022 | |
| IE | 18.02.2022 | ||
| Former [2022/21] | IE | 18.02.2022 | Documents cited: | Search | [I]WO9409010 (SANDOZ AG [AT], et al); | [I]WO9747317 (CIBA GEIGY AG [CH], et al); | [XP]WO0151049 (UNIV PENNSYLVANIA [US], et al); | Examination | US5206018 | by applicant | US4100274 | US4636505 | GB2177700 | US4659516 | EP0296110 | US5010099 | EP0520722 | EP0564409 | EP0566226 | WO9409010 | WO9410202 | US5362718 | WO9503283 | WO9516691 | WO9630347 | WO9633980 | WO9641807 | WO9702266 | EP0769947 | EP0787722 | WO9730034 | WO9738983 | WO9749688 | WO9811223 | WO9810767 | EP0837063 | US5747498 | WO9835958 | US5843901 | WO9903854 | WO9917804 | WO0009495 | WO0027820 | WO0027819 | WO0037502 | WO0059509 | other | WO9747317 | WO0069467 | WO02066019 | EP1363627 | EP3406249 | Opposition | GB2177700 | WO9409010 | WO9747317 | WO0069467 | WO0112633 | WO0151049 | WO0164193 | WO02066019 | GB104072 | GB124957 | EP1363267 | EP2269603 | EP2783686 | EP3143995 | EP3406249 | US5206018 | EP2269603 | WO02080975 | US5066493 | EP0663916 | US5922730 |